Results 81 to 90 of about 587,390 (283)

The Effect of Ondansetron on Decreasing the Hospitalization Rate in Children with Gastroenteritis and Recurrent Vomiting [PDF]

open access: yes, 2016
Background: Diarrhea is one of the most common disorders in infancy and childhood and recurrent vomiting is a main reason for hospitalization for these patients.
Darabi, Maryam   +2 more
core  

Cost‐effectiveness of DPYD genotyping prior to fluoropyrimidine‐based treatment for colorectal cancer in Wales

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Background Regulatory guidance in the United Kingdom advises DPYD genotyping prior to fluoropyrimidine‐based treatment. This economic evaluation estimated the costs and outcomes associated with DPYD screening prior to prescribing fluoropyrimidines for colorectal cancer in Wales and also considers additional variants to those included in ...
Catrin O. Plumpton   +8 more
wiley   +1 more source

EARLY AND LATE ASSESSMENT OF ESOPHAGOCARDIOPLASTY IN THE SURGICAL TREATMENT OF ADVANCED RECURRENT MEGAESOPHAGUS

open access: yesArquivos de Gastroenterologia
Background Since Chagas disease has esophageal manifestations with different degrees of involvement, the best surgical option is controversial, especially for patients with advanced chagasic megaesophagus and recurrent symptoms after previous treatment.
José Luis Braga de AQUINO   +5 more
doaj   +1 more source

Generalized recurrent and concircular recurrent manifolds [PDF]

open access: yes, 1999
The concepts of generalized recurrent manifold GK(n) and generalized concircular recurrent manifolds G(ZK(n)) are considered to prove that a manifold (M-n,g) which is either GK(n) or G(ZK(n)) is concircular recurrent manifold ZK(n).
Maralabhavi, Y.B., Rathnamma, M.
core  

Cyclic vomiting syndrome [PDF]

open access: yes, 2008
Siklik kusma sendromu belirli aralıklarla tekrarlayan, bulantı, kusma gibi semptomlarla karekterize bir hastalıktır. Bu semptomlar saatler ve günler boyunca devam eder. Ataklar arasındaki dönemde semptom yoktur.
Menteş, Sultan Ecer   +4 more
core   +1 more source

Pharmacokinetics and safety of tezepelumab in children with mild, moderate or severe asthma and adolescents with mild‐to‐moderate asthma

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Aim Tezepelumab is a human monoclonal antibody that blocks the activity of thymic stromal lymphopoietin and is approved for adolescents and adults with severe asthma. This analysis assessed pharmacokinetics (PK), pharmacodynamics and safety of tezepelumab up to 85 days postdose in adolescents and children.
Anna Lundahl   +14 more
wiley   +1 more source

Symptoms of Imminent Eclampsia Among Women Attending Care at Muhimbili National Hospital: A Case Refferent Study [PDF]

open access: yes, 2011
Preeclampsia affects about 5 to 10% of all pregnancies and eclamptic seizure is one of its serious complications. In many developing countries including Tanzania, maternal and perinatal mortality due to eclampsia are high.
France, John
core  

Motion sickness, stress and the endocannabinoid system [PDF]

open access: yes, 2010
A substantial number of individuals are at risk for the development of motion sickness induced nausea and vomiting (N&V) during road, air or sea travel.
Kreth Simone   +26 more
core   +2 more sources

Histamine and the mechanisms of nausea and vomiting: Translating the uncertain pharmacology of cyclizine

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Cyclizine is a long‐established, short‐acting drug, registered for preventing motion sickness, post‐operative nausea and vomiting (PONV) and ‘vomiting of known cause’. The latter is not defined but may include pregnancy and patients receiving palliative care, historically accepted without large, controlled trials.
Gareth J. Sanger, Paul L. R. Andrews
wiley   +1 more source

Phase Ib study of anlotinib combined with TQB2450 in pretreated advanced biliary tract cancer and biomarker analysis

open access: yesHepatology, EarlyView., 2022
Phase 1b study of anlotinib combined with TQB2450 in pretreated advanced biliary tract cancer and biomarker analysis. Abstract Background and Aims We evaluated the efficacy and safety of the antiangiogenic tyrosine kinase inhibitor anlotinib plus TQB2450, a programmed death‐ligand 1 inhibitor in pretreated advanced biliary tract cancers (BTCs ...
Jun Zhou   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy